Pancreatic cancer, also known as pancreatic ductal adenocarcinoma, is one of the most aggressive types of cancer. Despite advances in modern medicine, survival rates remain very low, and many patients ...

Pancreatic cancer survival has finally doubled in a decade to 13 percent, a fragile but real sign that years of slow, methodical progress are beginning to add up. November is Pancreatic Cancer ...

Advances in targeted therapies, especially those targeting KRAS mutations, and cancer vaccines show promise in pancreatic ...

KRAS inhibitors, cancer vaccines, and cell therapies are promising advancements in pancreatic cancer treatment, potentially improving patient outcomes. Innovative drug delivery techniques aim to ...

A new study from Yale School of Medicine researchers has found a positive link between chronic hepatitis C and pancreatic ...

Last year, researchers at the University of California, Riverside, developed a novel "molecular crowbar" strategy to degrade ...

Pancreatic Cancer Awareness Month highlights the growing concern in Washington as the disease claims lives rapidly.

Pancreatic cancer is often called a silent killer because it shows a few symptoms until it progresses to fatal stages.

CHICAGO, IL AND FORT WORTH, TX / ACCESS Newswire / August 25, 2025 / Vexing challenges await cancer researchers every day -- not just in finding new molecules -- but now, increasingly, in finding new ...

Pancreatic ductal adenocarcinoma is projected to become the second-leading cause of cancer death in the United States by 2030 ...